Penicillin

Sandoz Opens Antibiotic Production Facility in Austria

Sandoz, a generic and biosimilar medicines manufacturer, recently opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.

Sandoz Invests in Extra European Antibiotic Capacity

Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to spend an additional €50 million on raising European manufacturing capacity for finished dosage forms of amoxicillin and other key penicillin products.

FDA Warns GSK on Contamination at UK Plant

Pfizer Takes its Shot at a Vaccine for Evasive Superbug

Penicillin: Dr. Reddy's Buys Glaxo's U.S. Business